Below is a structured summary of the key points about hormone testing in perimenopause and what major guidelines actually recommend.SourcesHarlow SD, Gass M, Hall JE, et al. Executive summary of the Stages of Reproductive Aging Workshop +10. J Clin Endocrinol Metab. 2012;97(4):1159–1168. doi:10.1210/jc.2011-3362.Randolph JF Jr, Zheng H, Sowers MR, et al. Change in follicle-stimulating hormone and estradiol across the menopausal transition: effect of age at the final menstrual period. J Clin Endocrinol Metab. 2011;96(3):746–754. doi:10.1210/jc.2010-1746.Stuenkel CA, Davis SR, Gompel A, et al. Treatment of symptoms of the menopause: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2015;100(11):3975–4011. doi:10.1210/jc.2015-2236.Sowers MF, Eyvazzadeh AD, McConnell D, et al. Anti-Mullerian hormone and inhibin B in the definition of ovarian aging and the menopause transition. J Clin Endocrinol Metab. 2008;93(9):3478–3483. doi:10.1210/jc.2008-0567.Martens KL, DeLoughery TG. Sex, lies, and iron deficiency: a call to change ferritin reference ranges. Hematology Am Soc Hematol Educ Program. 2023;2023(1):617–621. doi:10.1182/hematology.2023000494.El Khoudary SR, Aggarwal B, Beckie TM, et al. Menopause transition and cardiovascular disease risk. Circulation. 2020;142(25):e506–e532. doi:10.1161/CIR.0000000000000912.DMWritten byDr. Maya OkonkwoInternal medicine; ten years women's health, Internal medicine. Ten years in women's health.DRReviewed byDr. R. Chen, MDOB-GYN; NAMS-certified menopause practitioner, Board-certified OB-GYN, NAMS-certified menopause practitioner.